2016 annual financial data

Rigel Pharmaceuticals 2016 Financial results

Rigel Pharmaceuticals 2016 financial results with verified reported values.

Direct answer

Revenue was 20,383,000 USD.

Operating income was -69,741,000 USD and net income was -69,216,000 USD.
Operating cash flow was -75,889,000 USD.

Get free Rigel Pharmaceuticals email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
20,383,000 USD
Operating income
-69,741,000 USD
Net income
-69,216,000 USD
Operating cash flow
-75,889,000 USD